- Home
- NTRB vs FSEA Comparison
NTRB vs FSEA Comparison
Compare NTRB & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- FSEA
- Stock Information
- Founded
- NTRB 2016
- FSEA 1890
- Country
- NTRB United States
- FSEA United States
- Employees
- NTRB N/A
- FSEA N/A
- Industry
- NTRB Industrial Specialties
- FSEA Savings Institutions
- Sector
- NTRB Health Care
- FSEA Finance
- Exchange
- NTRB Nasdaq
- FSEA Nasdaq
- Market Cap
- NTRB 46.4M
- FSEA 43.6M
- IPO Year
- NTRB N/A
- FSEA N/A
- Fundamental
- Price
- NTRB $4.11
- FSEA $9.96
- Analyst Decision
- NTRB
- FSEA
- Analyst Count
- NTRB 0
- FSEA 0
- Target Price
- NTRB N/A
- FSEA N/A
- AVG Volume (30 Days)
- NTRB 26.3K
- FSEA 5.9K
- Earning Date
- NTRB 12-04-2024
- FSEA 11-08-2024
- Dividend Yield
- NTRB N/A
- FSEA N/A
- EPS Growth
- NTRB N/A
- FSEA N/A
- EPS
- NTRB N/A
- FSEA N/A
- Revenue
- NTRB $2,021,771.00
- FSEA $11,390,000.00
- Revenue This Year
- NTRB N/A
- FSEA N/A
- Revenue Next Year
- NTRB N/A
- FSEA N/A
- P/E Ratio
- NTRB N/A
- FSEA N/A
- Revenue Growth
- NTRB N/A
- FSEA N/A
- 52 Week Low
- NTRB $2.22
- FSEA $8.05
- 52 Week High
- NTRB $9.60
- FSEA $10.38
- Technical
- Relative Strength Index (RSI)
- NTRB 44.78
- FSEA 55.91
- Support Level
- NTRB $3.90
- FSEA $9.53
- Resistance Level
- NTRB $5.16
- FSEA $10.09
- Average True Range (ATR)
- NTRB 0.33
- FSEA 0.16
- MACD
- NTRB -0.01
- FSEA -0.03
- Stochastic Oscillator
- NTRB 27.04
- FSEA 54.90
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.